SCHEMBL7451276

SCHEMBL7451276

Cc1noc(C)c1S(=O)(=O)OC(=O)[C@@H](N)CNC(=O)OC(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.34
▸ SERPINE1 P05121 1/20 0.34
▸ GAA P10253 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ PCSK9 Q8NBP7 1/20 0.33
▸ POLB P06746 4/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ ACACB O00763 1/20 0.33
▸ CA12 O43570 2/20 0.32
▸ CA1 P00915 2/20 0.32
▸ CA2 P00918 2/20 0.32
▸ CA9 Q16790 2/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ SYK P43405 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9093406 0.75 ITGB3 (0.57) —
SCHEMBL7367849 0.74 SYK (0.46) MAPTCA12CA1CA2CA9
SCHEMBL7369001 0.72 CA2 (0.41) KMT2AALDH1A1CA12CA1CA2
SCHEMBL7365846 0.71 MEN1 (0.36) SERPINE1GAAMEN1KMT2ACA12
SCHEMBL27711551 0.71 MEN1 (0.45) SERPINE1GAAMEN1KMT2ACA12
SCHEMBL9095656 0.70 CA12 (0.38) SERPINE1GAAMEN1KMT2ACA12
SCHEMBL7416225 0.70 CYP1A2 (0.43) MAPTSERPINE1GAAMEN1KMT2A
SCHEMBL8127521 0.70 CYP1A2 (0.43) MAPTSERPINE1GAAMEN1KMT2A
SCHEMBL7416221 0.70 CYP1A2 (0.43) MAPTSERPINE1GAAMEN1KMT2A
Hydrochloric Acid SCHEMBL3894157 0.70 MEN1 (0.44) SERPINE1GAAMEN1KMT2ACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0832077-B1 IMPROVED ISOXAZOLINE FIBRINOGEN RECEPTOR ANTAGONISTS DU PONT PHARM CO (US) 2001-11-14 — — EP disclosed
EP-0832077-A1 IMPROVED ISOXAZOLINE FIBRINOGEN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-04-01 — — EP disclosed
WO-1996037482-A1 IMPROVED ISOXAZOLINE FIBRINOGEN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-11-28 — — WO disclosed
Send feedback